Difei Yang
Stock Analyst at Mizuho
(2.16)
# 2,889
Out of 5,050 analysts
33
Total ratings
31.03%
Success rate
11.79%
Average return
Main Sectors:
Stocks Rated by Difei Yang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AKBA Akebia Therapeutics | Downgrades: Neutral | $6 → $2 | $2.04 | -1.96% | 4 | Mar 31, 2022 | |
| NVCR NovoCure | Maintains: Neutral | $229 → $200 | $10.92 | +1,731.50% | 6 | Jul 30, 2021 | |
| CASI CASI Pharmaceuticals | Initiates: Buy | $38 | $1.38 | +2,653.62% | 1 | Apr 26, 2021 | |
| FGEN FibroGen | Downgrades: Neutral | $725 | $11.03 | +6,472.98% | 4 | Apr 7, 2021 | |
| QURE uniQure | Upgrades: Buy | $52 | $27.79 | +87.12% | 4 | Apr 1, 2021 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $158 → $160 | $17.63 | +807.54% | 2 | Feb 26, 2021 | |
| XERS Xeris Biopharma Holdings | Maintains: Buy | $18 → $14 | $7.43 | +88.43% | 4 | Apr 23, 2020 | |
| NKTR Nektar Therapeutics | Upgrades: Buy | $315 → $525 | $55.97 | +838.00% | 4 | Feb 3, 2020 | |
| BOLD Boundless Bio | Upgrades: Buy | n/a | $1.22 | - | 2 | Aug 8, 2018 | |
| RGNX REGENXBIO | Initiates: Neutral | $28 | $11.21 | +149.78% | 1 | Feb 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.10 | +2,445.45% | 1 | Sep 27, 2017 |
Akebia Therapeutics
Mar 31, 2022
Downgrades: Neutral
Price Target: $6 → $2
Current: $2.04
Upside: -1.96%
NovoCure
Jul 30, 2021
Maintains: Neutral
Price Target: $229 → $200
Current: $10.92
Upside: +1,731.50%
CASI Pharmaceuticals
Apr 26, 2021
Initiates: Buy
Price Target: $38
Current: $1.38
Upside: +2,653.62%
FibroGen
Apr 7, 2021
Downgrades: Neutral
Price Target: $725
Current: $11.03
Upside: +6,472.98%
uniQure
Apr 1, 2021
Upgrades: Buy
Price Target: $52
Current: $27.79
Upside: +87.12%
Sarepta Therapeutics
Feb 26, 2021
Maintains: Buy
Price Target: $158 → $160
Current: $17.63
Upside: +807.54%
Xeris Biopharma Holdings
Apr 23, 2020
Maintains: Buy
Price Target: $18 → $14
Current: $7.43
Upside: +88.43%
Nektar Therapeutics
Feb 3, 2020
Upgrades: Buy
Price Target: $315 → $525
Current: $55.97
Upside: +838.00%
Boundless Bio
Aug 8, 2018
Upgrades: Buy
Price Target: n/a
Current: $1.22
Upside: -
REGENXBIO
Feb 13, 2018
Initiates: Neutral
Price Target: $28
Current: $11.21
Upside: +149.78%
Sep 27, 2017
Initiates: Buy
Price Target: $28
Current: $1.10
Upside: +2,445.45%